❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ Project groups Tumor Biology ❭ Karianne Giller Fleten ❭ Research interests ❭

Our main projects are:

Improving treatment of peritoneal metastasis using nanoparticles 

HIPEC model in vivo

 
Scroll to top

Home Project groups Tumor Biology Karianne Giller Fleten

  • Group members
  • Research interests
    • Improving treatment of peritoneal metastasis with nanoparticles
    • HIPEC model in vivo
  • Publications

Recent publications

Abrantes R, Forcados C, Warren DJ, Santos-Ferreira L, Fleten KG, Senra E, Costa AF, Krpina K, Henrique R, Liberg AM, Rawat P, Gelebart P, McCormack E, Bjørge L, Davidson B, Greiff V, Costea DE, Pinto F, Flatmark K, Gomes C, Inderberg EM, Reis CA, Wälchli S (2025)
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors
Cell Rep Med, 6 (9), 102350
DOI 10.1016/j.xcrm.2025.102350, PubMed 40925376

Andersson Y, Løvstakken E, Herud TM, Waagene S, Flatmark K, Fleten KG (2025)
Intraperitoneal Perfusion with Cisplatin or Mitomycin C Improves Survival in Mice Bearing Peritoneal Metastases from Ovarian Cancer
Ann Surg Oncol (in press)
DOI 10.1245/s10434-025-18025-x, PubMed 40788597

Andersson Y, Løvstakken E, Herud TM, Waagene S, Flatmark K, Fleten KG (2025)
ASO Visual Abstract: Intraperitoneal Perfusion with Cisplatin or Mitomycin C Improves Survival in Mice Bearing Peritoneal Metastases from Ovarian Cancer
Ann Surg Oncol (in press)
DOI 10.1245/s10434-025-18467-3, PubMed 41046292

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)